Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 314Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaTher Updates on FDA NDA for Ketamine
    PharmaTher Updates on FDA NDA for Ketamine

    26 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/26/2987445/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    26 Nov 2024
    Share Share
    PharmaTher Updates on FDA NDA for Ketamine
    PharmaTher Updates on FDA NDA for Ketamine

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983534/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share
    NRX-100 (Ketamine) Reaches Stability Milestone
    NRX-100 (Ketamine) Reaches Stability Milestone

    30 Sep 2024

    // CONTRACT PHARMA

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-completion-of-twelve-months-of-stability-on-the-first-manufactured-commercial-scale-lot-of-nrx-100-ketamine-302262032.html

    CONTRACT PHARMA
    30 Sep 2024
    Share Share
    Ketabon To Present At-Home Ketamine Therapy At ECNP 2024
    Ketabon To Present At-Home Ketamine Therapy At ECNP 2024

    18 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/18/2948187/0/en/Ketabon-To-Present-Advancements-In-At-Home-Ketamine-Therapy-For-Treatment-Resistant-Depression-At-ECNP-Congress-2024.html

    GLOBENEWSWIRE
    18 Sep 2024
    Share Share
    PharmaTher Announces Update on FDA NDA for Ketamine
    PharmaTher Announces Update on FDA NDA for Ketamine

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940433/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    SciSparc-Clearmind Ketamine-Based Combination Patent Application Published
    SciSparc-Clearmind Ketamine-Based Combination Patent Application Published

    29 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/29/2938125/0/en/SciSparc-Clearmind-Medicine-Collaboration-Leads-to-Publication-of-Application-for-Innovative-Ketamine-Based-Combination.html

    GLOBENEWSWIRE
    29 Aug 2024
    Share Share